Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 72 citing articles:

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, et al.
Annals of Oncology (2020) Vol. 31, Iss. 2, pp. 171-190
Open Access | Times Cited: 807
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Neha Bansal, M. Jacob Adams, Sarju Ganatra, et al.
Cardio-Oncology (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 159
Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention
Anchit Bhagat, Eugenie S. Kleinerman
Advances in experimental medicine and biology (2020), pp. 181-192
Closed Access | Times Cited: 157
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity
Torbjørn Omland, Siri Lagethon Heck, Geeta Gulati
JACC CardioOncology (2022) Vol. 4, Iss. 1, pp. 19-37
Open Access | Times Cited: 99
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines
Carlos A. Gongora, Zsófia D. Drobni, Thiago Quinaglia Araujo Costa Silva, et al.
JACC Heart Failure (2022) Vol. 10, Iss. 8, pp. 559-567
Open Access | Times Cited: 98
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 94
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 81
Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
Rachel E. Ohman, Eric H. Yang, Melissa L. Abel
Journal of the American Heart Association (2021) Vol. 10, Iss. 24
Open Access | Times Cited: 63
Advances in Multimodality Imaging in Cardio-Oncology
Lauren A. Baldassarre, Sarju Ganatra, Juan Lopez‐Mattei, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 16, pp. 1560-1578
Open Access | Times Cited: 58
Permissive Cardiotoxicity
Charles Porter, Tariq U. Azam, Divyanshu Mohananey, et al.
JACC CardioOncology (2022) Vol. 4, Iss. 3, pp. 302-312
Open Access | Times Cited: 48
Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model
Patricia Lorena Dulf, Mihaela Mocan, Camelia Alexandra Coadă, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 6, pp. 1105-1115
Open Access | Times Cited: 35
Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
Hany Akeel Al-Hussaniy, Ali Hikmat Alburghaif, Zahraa Alkhafaje, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 4, pp. 491-500
Open Access | Times Cited: 32
An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
Sicong Xie, Yuwei Sun, Xuan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Christos Kourek, Maria Touloupaki, Athanasios Rempakos, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 8, pp. 259-259
Open Access | Times Cited: 33
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Jacqueline Vuong, Ashley Stein-Merlob, Richard K. Cheng, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
Susmita Parashar, Nausheen Akhter, Elisavet Paplomata, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 2, pp. 159-173
Open Access | Times Cited: 16
Preventive Cardio-Oncology: The Time Has Come
Sherry‐Ann Brown
Frontiers in Cardiovascular Medicine (2020) Vol. 6
Open Access | Times Cited: 42
Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines
Jenica N. Upshaw, Susan K. Parson, Rachel J. Buchsbaum, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 322-324
Open Access | Times Cited: 5
Mechanisms of anthracycline-mediated cardiotoxicity and preventative strategies in women with breast cancer
Sonu S. Varghese, Cameron R. Eekhoudt, Davinder S. Jassal
Molecular and Cellular Biochemistry (2021)
Closed Access | Times Cited: 32
Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy
Wei Huang, Rong Xu, Bin Zhou, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
Jenica N. Upshaw, Jason Nelson, Angie Mae Rodday, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 5, pp. 453-453
Open Access | Times Cited: 12
Mechanisms of Cardiovascular Toxicities Induced by Cancer Therapies and Promising Biomarkers for Their Prediction: A Scoping Review
Tingting Yan, Hailong Yu, Tai Li, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 5, pp. 605-638
Closed Access | Times Cited: 4
Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity
Barbara Buchalska, Katarzyna Kamińska, Michał Kowara, et al.
Cardiovascular Toxicology (2025)
Closed Access
Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses
Haoyi Zheng, Huichun Zhan
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis
Lana Kattan, Sara M. Abulola, Mohamed Izham Mohamed Ibrahim, et al.
Cardiovascular Toxicology (2025)
Open Access
Page 1 - Next Page

Scroll to top